Patrycja Michalska Selected Research

luotonin A

10/2021

Enhanced Stability and Bioactivity of Natural Anticancer Topoisomerase I Inhibitors through Cyclodextrin Complexation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patrycja Michalska Research Topics

Disease

7	Neuroinflammatory Diseases 08/2020 - 01/2015
4	Brain Ischemia (Cerebral Ischemia) 02/2017 - 12/2015
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 11/2016
2	Neuroblastoma 01/2022 - 10/2021
2	Inflammation (Inflammations) 01/2022 - 02/2020
2	Neoplasms (Cancer) 10/2021 - 10/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2020 - 01/2015
1	Parkinson Disease (Parkinson's Disease) 01/2022
1	Carcinoma (Carcinomatosis) 10/2021
1	Blindness (Hysterical Blindness) 02/2020
1	Retinal Degeneration 02/2020
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 02/2020
1	Cognitive Dysfunction 08/2019
1	Proteostasis Deficiencies 08/2019
1	Tauopathies 08/2019
1	Hemolysis 01/2019
1	Fibrosarcoma 10/2018
1	Stroke (Strokes) 12/2015
1	Infarction (Infarctions) 12/2015
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2015

Drug/Important Bio-Agent (IBA)

6	AntioxidantsIBA 07/2020 - 01/2015
4	MelatoninIBA 08/2019 - 01/2015
3	Proteins (Proteins, Gene)FDA Link 08/2020 - 01/2015
3	ITH12674IBA 02/2020 - 02/2017
2	Neuroprotective AgentsIBA 01/2022 - 12/2015
2	Okadaic AcidIBA 01/2022 - 01/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 10/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 12/2015
2	ITH14001IBA 01/2017 - 01/2017
2	CalciumIBA 01/2017 - 01/2017
2	Oxygen (Dioxygen)IBA 01/2017 - 12/2015
2	Glutamic Acid (Glutamate)FDA Link 01/2017 - 12/2015
1	Monoamine Oxidase (MAO)IBA 01/2022
1	AcidsIBA 01/2022
1	RotenoneIBA 01/2022
1	OligomycinsIBA 01/2022
1	NAD(P)H Dehydrogenase (Quinone) (Quinone Reductase)IBA 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 01/2022
1	luotonin AIBA 10/2021
1	CyclodextrinsIBA 10/2021
1	CamptothecinIBA 10/2021
1	AlkaloidsIBA 10/2021
1	1,4-dihydropyridine (dihydropyridine)IBA 07/2020
1	Phosphotransferases (Kinase)IBA 07/2020
1	tau Proteins (tau Protein)IBA 07/2020
1	Retinaldehyde (Retinal)IBA 02/2020
1	Caspase 3 (Caspase-3)IBA 08/2019
1	phenylhydrazine (phenylhydrazine hydrochloride)IBA 01/2019
1	sulforaphaneIBA 01/2019
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	Heme (Haem)IBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 10/2018
1	PlatinumIBA 10/2018
1	ProdrugsIBA 02/2017
1	Pharmaceutical PreparationsIBA 02/2017
1	Dihydrotachysterol (AT 10)IBA 01/2017
1	Tacrine (Cognex)FDA Link 11/2016
1	Thioctic Acid (Lipoic Acid)IBA 11/2016
1	Formaldehyde (Formol)FDA Link 11/2016
1	Cyanides (Isocyanides)IBA 11/2016
1	Cholinesterases (Cholinesterase)IBA 11/2016
1	N- (2- (5- methoxy- indol- 3- yl)- ethyl)- 4- oxo- 4H- pyran- 2- carboxamideIBA 12/2015
1	MT2 Melatonin ReceptorIBA 12/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2015
1	Melatonin Receptors (Melatonin Receptor)IBA 12/2015
1	CinnamatesIBA 01/2015

Therapy/Procedure

1	Intraperitoneal Injections 01/2019
1	Adjuvant Chemotherapy 10/2018
1	Therapeutics 11/2016